Georgetown University
Multiligament knee reconstruction with suture tape yielded acceptable results at 2 years
Patients who underwent multiligament knee reconstruction with suture tape augmentation had acceptable clinical and patient-reported outcomes at 2-year follow-up, according to published results.
‘Disappointing’ data confirm aspirin does not reduce risk for breast cancer relapse
Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.
From surgeon to patient: Loss of certainty is real
I don’t know if I was already unconscious before I hit the pavement or not, but I was out cold. Blood was flowing out of my head when they found me.
Exclusive e-cigarette use not linked to heightened risk for wheeze
Use of only electronic-nicotine delivery systems did not raise the odds for wheezing; however, when used in current and former cigarette smokers, it showed a small elevated risk, according to study results published in JAMA Network Open.
Discrimination linked to frailty among Black cancer survivors
Major discrimination events appeared associated with increased frailty among Black survivors of various cancer types, according to study results published in Cancer.
High grit scores associated with scholarly productivity in orthopedic residents
DALLAS — Presented results showed high grit scores were associated with mental toughness, scholarly productivity and academic involvement in orthopedic surgery residents.
Use of antibiotics safe during durvalumab-based treatment for biliary tract cancer
Patients with advanced biliary tract cancer can safely use antibiotics while benefiting from treatment with durvalumab plus gemcitabine and cisplatin, according to study results presented at ASCO Gastrointestinal Cancers Symposium.
Efgartigimod confers rapid improvement in platelet counts in immune thrombocytopenia
NEW ORLEANS — Efgartigimod demonstrated clinically significant improvement in platelet counts compared with placebo among adults with primary immune thrombocytopenia, results of the phase 3 ADVANCE IV trial showed.
Tivozanib confers long-term PFS benefit in advanced renal cell carcinoma
Tivozanib improved long-term PFS compared with sorafenib among patients with relapsed or refractory advanced renal cell carcinoma, according to study results.
Every voice matters and every vote counts: We must vote for our health this November
We are just over 2 months away from the Nov. 8 election, and now is the time to ensure that every eligible person in our nation is registered to vote, is ready and committed to casting their ballot and has the supports needed to vote.